Physical, Chemical and Pharmacological Characterization of a New Oleogel-Forming Triterpene Extract from the Outer Bark of Birch (Betulae Cortex)

 

 Buy Article Permissions and Reprints

Abstract

Triterpenes are biologically active secondary plant substances that display antimicrobial, hepatoprotective and anti-inflammatory effects. However, the poor solubility of triterpenes in both polar and non-polar solvents as well as expensive purification procedures have prevented the large-scale isolation of these compounds for medicinal purposes. Here, we describe a novel quantitative extraction method of triterpenes from the outer bark of birch (Betula species) in which betulin, a lupan triterpene, predominates. The resulting highly purified triterpene extract (TE) in the form of a dry powder contains betulin as the major compound, but also betulinic acid, lupeol, erythrodiol and oleanolic acid. We have found that this TE is able to form an oleogel, thus providing an opportunity for the topical application of pharmacologically relevant amounts of triterpenes. Furthermore, we have investigated the TE in comparison to its major isolated compounds in cell culture experiments with human immortalized keratinocytes and skin cancer cells. We could demonstrate dose-dependent cytotoxic and apoptosis-inducing effects of TE and betulin. These experimental data support the notion from a previous clinical study that TE from the outer bark of birch might represent a new tool for the topical treatment of skin cancer and skin cancer precursors like actinic keratoses.

References

• 1 Liu J. Oleanolic acid and ursolic acid: research perspectives.  J Ethnopharmacol. 2005;  100 92-4
  CrossrefPubMedGoogle Scholar
• 2 Jäger S, Scheffler A, Schmellenkamp H. Pharmakologie ausgewählter Terpene.  Pharm Ztg. 2006;  151 2082-93
  PubMedGoogle Scholar
• 3 Yogeeswari P, Sriram D. Betulinic acid and its derivatives: a review on their biological properties.  Curr Med Chem. 2005;  12 657-66
  PubMedGoogle Scholar
• 4 Ekman R. The submarin monomers and triterpenoids from the outer bark of Betula verrucosa EHRH.  Holzforschung. 1983;  37 205-11
  CrossrefPubMedGoogle Scholar
• 5 Pavlova N I, Savinova O V, Nikolaeva S N, Boreko E I, Flekhter O B. Antiviral activity of betulin, betulinic and betulonic acids against some enveloped and non-enveloped viruses.  Fitoterapia. 2003;  74 489-92
  CrossrefPubMedGoogle Scholar
• 6 Woldemichael G M, Singh M P, Maiese W M, Timmermann B N. Constituents of antibacterial extract of Caesalpinia paraguariensis BURK.  Z Naturforsch [C]. 2003;  58 70-5
  PubMedGoogle Scholar
• 7 Aiken C, Chen C H. Betulinic acid derivatives as HIV-1 antivirals.  Trends Mol Med. 2005;  11 31-6
  CrossrefPubMedGoogle Scholar
• 8 Eiznhamer D A, Xu Z Q. Betulinic acid: a promising anticancer candidate.  Drugs. 2004;  7 359-73
  PubMedGoogle Scholar
• 9 Fulda S, Scaffidi C, Susin S A, Krammer P H, Kroemer G, Peter M E. et al . Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid.  J Biol Chem. 1998;  273 33 942-8
  PubMedGoogle Scholar
• 10 Oh S H, Choi J E, Lim S C. Protection of betulin against cadmium-induced apoptosis in hepatoma cells.  Toxicology. 2006;  220 1-12
  CrossrefPubMedGoogle Scholar
• 11 Reyes C P, Nunez M J, Jimenez I A, Busserolles J, Alcaraz M J, Bazzocchi I L. Activity of lupane triterpenoids from Maytenus species as inhibitors of nitric oxide and prostaglandin E₂ .  Bioorg Med Chem. 2006;  14 1573-9
  CrossrefPubMedGoogle Scholar
• 12 Recio M C, Giner R M, Manez S, Gueho J, Julien H R, Hostettmann K. et al . Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucomelas .  Planta Med. 1995;  61 9-12
  Article in Thieme ConnectPubMedGoogle Scholar
• 13 Giner-Larza E M, Manez S, Recio M C, Giner R M, Prieto J M, Cerda-Nicolas M. et al . Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity.  Eur J Pharmacol. 2001;  428 137-43
  CrossrefPubMedGoogle Scholar
• 14 Fernandez M A, de las Heras B, Garcia M D, Saenz M T, Villar A. New insights into the mechanism of action of the anti-inflammatory triterpene lupeol.  J Pharm Pharmacol. 2001;  53 1533-9
  CrossrefPubMedGoogle Scholar
• 15 Manez S, Recio M C, Giner R M, Rios J L. Effect of selected triterpenoids on chronic dermal inflammation.  Eur J Pharmacol. 1997;  334 103-5
  CrossrefPubMedGoogle Scholar
• 16 Scheffler A. Emulsion containing a triterpene containing plant extract, method for producing said emulsion and for obtaining a plant extract. US Patent US2003087789 2003
  Google Scholar
• 17 Mie G. Beiträge zur Optik trüber Medien, speziell kolloidaler Metalllösungen.  Annalen der Physik. 1908;  4 377-445
  PubMedGoogle Scholar
• 18 Brunauer S, Emmett P H, Teller E. Adsorption of gases in multimolecular layers.  J Am Chem Soc. 1938;  60 309
  CrossrefPubMedGoogle Scholar
• 19 Schempp C M, Kirkin V, Simon-Haarhaus B, Kersten A, Kiss J, Termeer C C. et al . Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John’s wort that acts by induction of apoptosis.  Oncogene. 2002;  21 242-50
  PubMedGoogle Scholar
• 20 Schempp C M, Kiss J, Kirkin V, Averbeck M, Simon-Haarhaus B, Kremer B. et al . Hyperforin acts as an angiogenesis inhibitor in vitro and in vivo .  Planta Med. 2005;  71 999-1004
  Article in Thieme ConnectPubMedGoogle Scholar
• 21 Rimpler H, Kuhn H, Leuckert C. Die Triterpene von Betula pendula ROTH und Betula pubescens EHRH.  Arch Pharm. 1966;  299 422-8
  CrossrefPubMedGoogle Scholar
• 22 Römpp . Lexikon der Chemie. Band 2 Thieme Stuttgart; Falbe J, Regitz M editors 1990: 1511
  Google Scholar
• 23 Töricht E, Erös I. Study of ointments with highly dispersed silicium oxide. 1. Rheologic properties of gels with hydrophilic or hydrophobic Aerosil and Syloid.  Pharmazie. 1977;  32 109-10
  PubMedGoogle Scholar
• 24 Bauer K H, Frömming K H, Führer C. Lehrbuch der pharmazeutischen Technologie. Stuttgart; Wissenschaftliche Verlagsgesellschaft 2002: 285-6
  Google Scholar
• 25 Crouch S P, Kozlowski R, Slater K J, Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.  J Immunol Methods. 1993;  160 81-8.
  PubMedGoogle Scholar
• 26 Dudai N, Weinstein Y, Krup M, Rabinski T, Ofir R. Citral is a new inducer of caspase-3 in tumor cell lines.  Planta Med. 2005;  71 84-8
  Article in Thieme ConnectPubMedGoogle Scholar
• 27 Kasperczyk H, La Ferla-Bruhl K, Westhoff M A, Behrend L, Zwacka R M, Debatin K M. et al . Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy.  Oncogene. 2005;  24 945-56
  CrossrefPubMedGoogle Scholar
• 28 Galgon T, Wohlrab W, Drager B. Betulinic acid induces apoptosis in skin cancer cells and differentiation in normal human keratinocytes.  Exp Dermatol. 2005;  14 36-43
  PubMedGoogle Scholar
• 29 Huyke C, Laszczyk M, Scheffler A, Ernst R, Schempp C M. Treatment of actinic keratoses with birch bark extract: a pilot study.  J Dtsch Dermatol Ges. 2006;  4 132-6
  PubMedGoogle Scholar

Christoph M. Schempp

Department of Dermatology

University of Freiburg

Hauptstrasse 7

79104 Freiburg

Germany

Phone: +49-761-974-911

Fax: +49-761-6829

Email: cschempp@haut.ukl.uni-freiburg.de

• Supplementary Material